Etomidate Injection — Class II drug recall D-1065-2019
Terminated recall by Heritage Pharmaceuticals, Inc., reported 2019-03-27, distributed nationwide. Subpotent Drug.
| Recall number | D-1065-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Heritage Pharmaceuticals, Inc., East Brunswick, NJ, United States |
| Recall initiated | 2019-02-15 |
| Classified | 2019-03-27 |
| Reported by FDA | 2019-03-27 |
| Terminated | 2021-03-04 |
| Distributed | Nationwide (US) |
| Quantity | 11,888 units |
| Reason classes | potency |
| NDC | 23155-0160-31 |
| Lot numbers | AMA701, AMA702, AMA703 |
| Expiration dates | 2019-03-20, 2019-08-20 |
Product
Etomidate Injection, USP 20 mg/10mL (2mg/mL) 10 mL Single-Dose Vial, Rx only, Manufactured for: Heritage Pharmaceuticals Inc. Made in India, NDC 23155-160-31
Reason for recall
Subpotent Drug.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1065-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.